OVACE WASH Rx
Generic Name and Formulations:
Sodium sulfacetamide 10%.
Mission Pharmacal Company
Indications for OVACE WASH:
Seborrheic dermatitis. Dandruff. Secondary cutaneous bacterial infection.
Seborrheic dermatitis and dandruff: Wash affected areas twice daily (AM & PM). Apply to affected areas, massage into skin, rinse thoroughly, pat dry and repeat after 10–20 seconds. Repeat for 8–10 days; reduce frequency as conditon improves. Secondary cutaneous bacterial infection: Massage into skin for 10–20 seconds then rinse; repeat for 8–10 days.
Discontinue if sensitization, rash, arthritis, fever or mouth sores develop. Avoid eyes, mucous membranes, broken skin. Pregnancy (Cat.C). Nursing mothers.
Incompatible with silver preparations.
Local irritation; rare: Stevens-Johnson syndrome, systemic lupus erythematosus, systemic toxic reactions.
Wash—6oz, 12oz, 16oz
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Genetic Counseling Recommended for Advanced Prostate Cancer
- Higher-Dose Immunoglobulin Replacement Therapy in Chronic Lymphocytic Leukemia
- BRCA1/Shieldin Double Mutations May Signal Resistance to PARP Inhibitors
- "Impressive" CNS Responses With Osimertinib Compared With Standard EGFR-TKIs in Patients With CNS Metastases at Baseline
- Study Zeroes in on Cause of Castration-Resistant Prostate Cancer
- Higher Doses of Image-Guided Neoadjuvant Radiation Therapy Found to Be Safe in Locally Advanced NSCLC: Study
- Supply Shortages of Bacillus Calmette-Guérin Found to Spur Drug Rationing in Non-Muscle-Invasive Bladder Cancer
- Study Analyzing Postmarketing Data on Breast Implant Safety Sparks FDA Response
- Epacadostat and Pembrolizumab Combo Active in Relapsed NSCLC
- PD-1 Inhibitor Cemiplimab Shows Antitumor Activity in Relapsed NSCLC